{"SPADE_UN_15277": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15277", "Peptide Name": "L4", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "PAWFKARRWAWRMLKKAA", "Sequence Length": 18, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MT-1 (IC50=16 µM); Meth A (IC50=31 µM); HT-29 (IC50=57 µM)", "Hemolytic Activity": "Human red blood cells:EC50>440 µM", "Cytotoxicity": "Fibroblas:IC50=299 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C109H165N33O19S", "Mass": 2273.75, "PI": 12.0, "Net Charge": 6, "Hydrophobicity": -0.67, "Half Life": "Mammalian:>20 hourYeast:>20 hourE.coli:/", "Literature": [{"Title": "Enhanced antitumor activity and selectivity of lactoferrin-derived peptides", "Pubmed ID": "12366526", "Reference": "J Pept Res. 2002 Oct;60(4)187-97.", "Author": "Yang N, Stensen W, Svendsen JS, Rekdal Ø.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=12366526"}], "Frequent Amino Acids": "AKR", "Absent Amino Acids": "CDEGHINOQSTUVY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 12, "Polar Residues": 11, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_10421", "Similarity": 1.0, "Sequence": "KKAAHVGKHVGKAAKK"}, {"SPADE_ID": "SPADE_N_10422", "Similarity": 1.0, "Sequence": "KKAAHVGKHVGKAAL"}, {"SPADE_ID": "SPADE_UN_01049", "Similarity": 1.0, "Sequence": "KKAAAKAAAAAKAAWAAKAAAKKKK"}]}}}